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These results establish a requirement for GDP-fucose for
L. major viability and predict the existence of an essential
fucoconjugate(s).

Leishmania undergoes dramatic changes during its infectious cycle, alternating between a flagellated extracellular promastigote in the midgut of phlebotomine sand flies and an
intracellular amastigote residing within macrophages of the
mammalian host (1). Upon ingestion of a blood meal by the
sand fly vector, Leishmania parasites first need to attach to
the midgut to avoid excretion and undergo a period of replication and development, after which these procyclic promastigotes differentiate to unbound infective metacyclic
promastigotes, adapted for transmission to mammals (2).
Lipophosphoglycan (LPG),3 the most abundant glycoconjugate on the surface of promastigotes, has been implicated as an
adhesion molecule required for midgut attachment in several
Leishmania species (3).
LPG shows well-defined structural polymorphisms among
different Leishmania species, with a conserved heptasaccharide
core joined to a 1-O-alkyl-2-lysophosphatidylinositol anchor.
Attached to this glycan core, a long polymer of 15–30 disaccharide phosphate repeating units ([6Gal(␤1,4)Man(␣1)-PO4],
also termed phosphoglycan or PG repeats) extends linearly, terminating in a neutral capping oligosaccharide. Importantly, the
structure of LPG is developmentally regulated by varying the
capping oligosaccharide, the number of PG repeating units, and
side chain modifications to the PG repeats in a way characteristic of each Leishmania species and critical for interactions
with sand fly vector and survival following transmission into
the mammalian host (3). One extensively studied pairing
involves the interactions of Leishmania major strain Friedlin
V1 (LmFV1) with its natural host Phlebotomus papatasi (4, 5).
Procyclic promastigotes express LPG with PG repeats modified
by ␤1, 3-Gal side chain residues mediating binding to the
midgut lectin PpGalec (6), as demonstrated by biochemical and
3

The abbreviations used are: LPG, lipophosphoglycan; PG, phosphoglycan;
Fuc, L-fucose; Man, mannose; FKP, fucokinase-pyrophosphorylase; A/FKP,
arabino/fucokinase-pyrophosphorylase; FACE, fluorophore-assisted carbohydrate electrophoresis; nt, nucleotide(s); D-Arap, D-arabinopyranose;
UEA-I, U. europaeus agglutinin I; FU, fluorescence units; GMD, GDP-mannose 4,6-dehydratase; GMER, GDP-fucose synthetase; LmFV1, L. major
strain Friedlin V1.
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To survive in its sand fly vector, the trypanosomatid protozoan parasite Leishmania first attaches to the midgut to avoid
excretion, but eventually it must detach for transmission by the
next bite. In Leishmania major strain Friedlin, this is controlled
by modifications of the stage-specific adhesin lipophosphoglycan (LPG). During differentiation to infective metacyclics,
D-arabinopyranose (D-Arap) caps the LPG side-chain galactose
residues, blocking interaction with the midgut lectin PpGalec,
thereby leading to parasite detachment and transmission. Previously, we characterized two closely related L. major genes
(FKP40 and AFKP80) encoding bifunctional proteins with
kinase/pyrophosphorylase activities required for salvage and
conversion of L-fucose and/or D-Arap into the nucleotide-sugar
substrates required by glycosyltransferases. Whereas only
AFKP80 yielded GDP-D-Arap from exogenous D-Arap, both
proteins were able to salvage L-fucose to GDP-fucose. We now
show that ⌬afkp80ⴚ null mutants ablated D-Arap modifications
of LPG as predicted, whereas ⌬fkp40ⴚ null mutants resembled
wild type (WT). Fucoconjugates had not been reported previously in L. major, but unexpectedly, we were unable to generate
fkp40ⴚ/afkp80ⴚ double mutants, unless one of the A/FKPs was
expressed ectopically. To test whether GDP-fucose itself was
essential for Leishmania viability, we employed “genetic
metabolite complementation.” First, the trypanosome de
novo pathway enzymes GDP-mannose dehydratase (GMD)
and GDP-fucose synthetase (GMER) were expressed ectopically; from these cells, the ⌬fkp40ⴚ/⌬afkp80ⴚ double mutant
was now readily obtained. As expected, the ⌬fkp40ⴚ/
⌬afkp80ⴚ/ⴙTbGMD-GMER line lacked the capacity to generate GDP-Arap, while synthesizing abundant GDP-fucose.

GDP-fucose is an essential metabolite for Leishmania

genetic studies of LPG and side-chain galactosylation-deficient
mutants (7). Upon differentiation to infective metacyclics,
LmFV1 synthesizes an LPG in which the side-chain Gal residues are capped with ␣1,2-D-arapyranose (D-Arap), which is
not recognized by midgut lectin and thus permits parasite disengagement in preparation for transmission (8 –10).
Arabinose exists naturally in both pyranose and furanose
conformations and D- and L-configurations. The most abundant form of arabinose is L-arabinose, which is present in the
arabinogalactans of plants. D-arabinofuranose (D-Araf) is found
mainly in the arabinomannans, arabinogalactans, lipoarabinomannans, and mycolylarabinogalactan-peptidogalactans of
mycobacterial cell walls. However, D-Arap is a rare sugar,
occurring in several cell surface glycoconjugate structures from
certain trypanosomatid parasites: L. major and Leishmania
donovani (11, 12), Crithidia fasciculata (13), and Endotrypanum spp. (14, 15). In trypanosomatids, D-Arap is synthesized de
novo by an as yet uncharacterized pathway or taken up from the
media and ultimately is converted to the active form GDP-Arap
(16). GDP-Arap is then transported into the parasite’s Golgi
apparatus through the activity of nucleotide sugar transporter
LPG2 (17, 18), where it then serves as the donor for arabinosylation of side-chain-galactosylated LPG by the arabinosyltransferases encoded by SCA1/2 (19, 20). Our knowledge of this
pathway is summarized in Fig. 1A.
Recently, we identified two closely related L. major genes
(LmjF16.0440 and LmjF16.0480) showing similarity to a
bifunctional kinase-phosphorylase mediating the salvage of
fucose to GDP-fucose in Bacteroides (21–23). Because D-Arap
is structurally similar to L-fucose (Fig. 1C), we asked whether
the Leishmania enzymes could synthesize GDP-Arap. Studies
of the two enzymes expressed from Escherichia coli showed
that only LmjF16.0480 was able to convert D-Ara through both
steps to GDP-Arap. LmjF16.0440 showed strong D-Arap kinase
activity but only trace pyrophosphorylase activity. This was

attributable to a 3-amino acid difference in the N-terminal
pyrophosphorylase enzymatic domain, because the two proteins are otherwise identical (22, 23).4 In contrast, when assayed
with L-fucose, both Leishmania proteins yielded GDP-fucose,
although the Vmax for the phosphorylase activity with fucose
1-phosphate of LmjF16.0480 was about 10-fold greater than for
LmjF16.0440 (22). Based on their enzymatic activities and their
ultimate metabolic role in providing activated GDP-sugar substrates, LmjF16.0480 was named AFKP80 (arabino/fucokinase/
pyrophosphorylase), whereas LmjF16.0440 was termed FKP40
(fucokinase/pyrophosphorylase) (22, 23).4 When referred to
collectively, the term A/FKP can be used.
Although the nature and roles of D-Arap-bearing glycoconjugates are well-known in L. major, fucose has never been
directly identified for any glycoconjugate isolated from this species. However, there are scattered reports of fucosylation in
other Leishmania species. The fucosylation of four proteins was
inferred from mass spectrometry and proteomics in L. donovani (24), and this species synthesizes several complex mannose-fucose-bearing antigens (25). When expressed heterologously in L. tarentolae, human erythropoietin was found
to bear a fucosylated biantennary N-glycan (26). The potential for fucosylation in L. major became apparent with the
discovery that this species showed significant levels of GDPfucose (27). Because L. major lacks the genes encoding the de
novo biosynthetic pathway from GDP-mannose to GDP-fucose (GDP-mannose 4,6-dehydratase (GMD) and GDP-fucose synthetase, also known as GDP-4-dehydro-6-deoxy-Dmannose epimerase/reductase (GMER) (28)), GDP-fucose
presumably arises via salvage of Fuc through A/FKPs. Fucose
may be acquired following digestion of fucosylated molecules abundant in the host or from medium serum supple4

N. M. Novozhilova, T. Notton, H. Guo, S. J. Turco, and S. M. Beverley, manuscript in preparation.
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Figure 1. D-Arap and L-fucose pathways in Leishmania and trypanosomes. A, L. major. Known metabolic steps (referenced in this paper or established by
this work) are depicted with solid arrows. D-Arap is known to be synthesized de novo, but the steps have not been determined as yet; both D-Arap and L-fucose
can be taken up, but the specific carrier(s) has not been established. The presence of fucosyltransferase acting in various cellular compartments is shown in this
work, but the specific enzymes and product conjugates remain to be determined. The salvage pathway to GDP-fucose is absent in T. brucei but present in
T. cruzi and humans. B, the two enzymes comprising the de novo pathway for synthesis of GDP-fucose from GDP-mannose. This pathway is absent in Leishmania
but present in T. brucei as well as T. cruzi and humans. C, the structures of D-arapyranose and L-fucose. The difference between them is circled.

GDP-fucose is an essential metabolite for Leishmania

ments. Trypanosoma brucei lacks A/FKPs and an active salvage pathway, and GDP-fuc synthesis by the de novo pathway
is essential (29).
To dissect the potentially overlapping roles of AFKP80 and
FKP40 in vivo and the relative contributions of D-Arap and
fucose to Leishmania biology, we focused on the role of A/FKPs
through the generation of null mutants. Surprisingly, whereas
we could generate ⌬fkp40⫺ and ⌬afkp80⫺ single mutants, we
were able to generate ⌬fkp40⫺/⌬afkp80⫺ double mutant only
in the presence of ectopically expressed AFKP80. Importantly,
rescue was also obtained following expression of the GDP-fucose de novo pathway genes GMD and GMER, thereby establishing that GDP-fucose is required for the survival of L. major.

Results
Generation of ⌬fkp40ⴚ or ⌬afkp80ⴚ null mutants
We created null mutants of the A/FKP genes individually by
homologous gene replacement of each ORF. Because the Leishmania genome is predominantly diploid, albeit with occasional
aneuploidy (30 –33), typically two rounds of gene targeting are
required to generate null mutants. Analysis of the L. major
genome (34) revealed that AFKP80 and FKP40 are located on
L. major chromosome 16, separated by about 12 kb of DNA
encoding at least three unrelated genes: LmjF16.0470 (hypothetical protein), LmjF16.0460 (60S ribosomal protein L21),
and LmjF16.0450 (hypothetical protein; Fig. 2A; labeled 70, 60,
and 50). This interspersed arrangement posed additional challenges for gene targeting, further complicated by the sequence
similarity between the two A/FKP genes (99.9% identity),
extending outside of their coding regions 540 nt on the 5⬘ side
and 110 nt on the 3⬘ side of the two A/FKP ORFs (Fig. 2A).
Reasoning that, as in other organisms, the specificity of homologous recombination is directed by the sequence of the invad-
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ing linear DNA termini, we used targeting sequences that
extended beyond the flanking homology into unique regions
(Fig. 2A).
For AFKP80, we designed constructs that precisely replaced
the AFKP80 ORF with ORFs conferring hygromycin (HYG) or
puromycin (PAC) resistance, flanked by ⬃1 kb of 5⬘ and 3⬘
AFKP80 sequence (Fig. 2A and supplemental Fig. S1). Successive transfections yielded numerous clonal lines at typical frequencies for Leishmania (⬃10 clones/g of DNA). Loss of the
AFKP80 ORF with retention of FKP40 in the presumptive
⌬afkp80⫺ mutants was demonstrated by PCR using a common
A/FKP ORF primer in combination with flanking primers specific for the right or left flanking regions of the AFK80 or FKP40
ORFs (Fig. 2A). Whereas control WT parasites showed both the
expected AFKP80 and FKP40 amplicons (Fig. 2 (B and C), lanes
labeled WT), the ⌬afkp80⫺ mutant showed loss of the AFKP80
but not FKP40 product (Fig. 2 (B and C), lanes labeled ⌬afkp⫺).
The planned replacement of AFKP80 was also confirmed by
PCR using primer pairs with one located outside of the targeting fragment to either the 5⬘ or 3⬘ side, partnered with HYG- or
PAC-specific primers (supplemental Fig. S1).
Similar constructs were made replacing the FKP40 ORF with
markers conferring blasticidin (BSD) or nourseothricin (SAT)
resistance. Loss of the FKP40 ORF with retention of the
AFKP80 ORF in the presumptive ⌬fkp40⫺ mutants was demonstrated by PCR showing loss of the FKP40 but not AFKP80
product (Fig. 2 (B and C), lanes labeled ⌬fkp⫺). Furthermore,
generation of the planned replacement of FKP40 was established by PCR using primer pairs, with one located outside of
the targeting fragment to either the 5⬘ or 3⬘ side, partnered with
BSD- or SAT-specific primers (supplemental Fig. S1).
As an additional control, we confirmed that the three ORFs
separating AFKP80 and FKP40 were intact. PCRs covering all of
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Figure 2. Generation of L. major ⌬afkp80ⴚ and ⌬fkp40ⴚ null mutants singly. A, map of the A/FKP locus. The ORFs for AFKP80 (LmjF16.0480) and FKP40
(LmjF16.0440) are shown in red and blue, respectively. The ORFs for the three intervening genes LmjF16.0470 (hypothetical protein), LmjF16.0460 (60S ribosomal
protein L21), and LmjF16.0450 (hypothetical protein) are shown in gray (labeled 70, 60, and 50). Narrow bars flanking A/FKP ORFs depict conserved flanking
regions shared by the two genes (gray, 5⬘; white, 3⬘) or the boundaries of the targeting fragments used for gene replacement (black). The locations of PCR
primers and predicted fragments described in B–D are shown above or below the central map. For clarity, the labels for AFKP80 or FKP40-specific products have
been colored red or blue, respectively; similarly, l or r designate PCR products probing the left (5⬘) or right (3⬘) flanking regions, respectively. Primer sequences
can be found in supplemental Table S1. The analysis of the marker replacement alleles is shown in supplemental Fig. S1. B, PCR analysis of left (5⬘) flanking
regions of FKP40 and AFKP80 in WT, ⌬fkp40⫺, and ⌬afkp80⫺. These PCRs establish the presence or loss of either or both of the A/FKP genes. Primer e (SMB2453)
is common for both A/FKP genes, primer d (SMB 2830) is specific for the AFKP80, and primer f (SMB2783) is specific for FKP40. C, PCR analysis of right (3⬘) flanking
regions of FKP40 and AFKP80 in WT, ⌬fkp40⫺, and ⌬afkp80⫺. These PCRs establish the presence or loss of A/FKP genes as expected. Primer a (SMB2451) is
common for A/FKP, primer b (SMB2793) is specific for AFKP80, and primer c (SMB2784) is specific for FKP40. D, PCR analysis of intervening genes in WT, ⌬fkp40⫺,
and ⌬afkp80⫺. These PCRs establish that the intervening genes are maintained intact as expected. Primers 2 ⫹ 3 (SMB3522, 3) amplify regions including the
LmF16.0450 ORF, primers 4 ⫹ 5 (SMB3524, 5) amplify the region including LmjF16.0460 ORF, and primers 6 ⫹ 7 (SMB3526, 7) amplify the region encompassing
the LmjF16.0470 ORF.

GDP-fucose is an essential metabolite for Leishmania
Although the close similarity of the two proteins precluded
determination of their relative expression, assuming the proteins are expressed at similar levels, the differences in Vmax
would predict 91% versus 9% activity in the ⌬fkp40⫺ versus
⌬afkp80⫺ mutants relative to WT, in reasonable agreement
with our data (Fig. 3).
Collectively, our findings establish that in vivo, AFKP80
encodes the dominant activity, contributing as expected all of
the GDP-Arap synthetic activity and the majority of total cellular GDP-fucose activity.

Figure 3. GDP-fucose and GDP-Arap synthesis in cytosolic extracts from
WT and A/FKP mutant Leishmania. Cytosolic extracts from WT, ⌬fkp40⫺,
and ⌬afkp80⫺ were incubated with [3H]fucose (left series) or [3H]D-Arap (right
series) and the production of radiolabeled GDP-fucose or GDP-Arap was
determined as described under “Experimental procedures.” Black bars, WT;
gray bars, ⌬fkp40⫺; white bars, ⌬afkp80⫺. The average and S.D. from three
independent experiments are shown, calculated using Microsoft Excel 2010.
For ⌬afkp80⫺, the numbers in parenthesis were calculated relative to WT.

Enzymatic activities of afkp80 and fkp40ⴚ mutants
We prepared cell extracts and evaluated their ability to support the synthesis of GDP-fucose or GDP-Arap from radiolabeled L-fucose or D-Arap in vitro. In WT parasite extracts, comparable activity was seen with either L-fucose or D-Arap (Fig. 3,
black bars). Thus, Leishmania parasites express a fucose salvage pathway with activity comparable with that of D-Arap.
GDP-Arap synthesis was unaffected in extracts from the
⌬fkp40⫺ mutant, as expected because the recombinant FKP40
enzyme is unable to synthesize GDP-Arap. Consistent with the
ability of recombinant AFKP80 to synthesize GDP-Arap in
vitro, ablation of this enzyme in the ⌬afkp80⫺ mutant reduced
GDP-Arap synthesis to trace levels (⬃1% of WT; Fig. 3). We
suspect that this reflects a residual ability of FKP40 to synthesize GDP-Arap that was not measurable in studies of the
recombinant enzyme.
GDP-fucose synthesis was not significantly affected in
extracts from the ⌬fkp40⫺ mutant but was reduced to 15% of
WT levels in the ⌬afkp80⫺ (Fig. 3, gray versus white bars).
Importantly, these data provide evidence that both enzymes
mediate GDP-fucose salvage, with the contribution of AFKP80
(present in ⌬fkp40⫺) being greater than that of FKP40 (present
in ⌬afkp80⫺). Quantitatively, these data are consistent with the
kinetic properties of the recombinant enzymes, which were
similar other than for the pyrophosphorylase reaction leading
to GTP-fucose synthesis from fucose 1-phosphate, where the
Vmax was about 10 times greater for AFKP80 than FKP40.

We examined the functional consequences of the single
A/FKP ablations by assessing the reactivity of the mutants with
monoclonal antibody 3F12, which recognizes arabinosylated
LPG, specifically the Arap(␣1,2)Gal(␤1,3)[6Gal(␤1,4)Man(␣1)PO4] phosphoglycan repeating units (35, 36). Parasites were
examined in both logarithmic and stationary phase, a time
when metacyclogenesis accompanied by up-regulation of LPG
arabinosylation occurs (19). As expected, all log phase parasites
showed little reactivity with 3F12 (data not shown). In stationary phase, WT and ⌬fkp40⫺ mutant parasites showed strong
reactivity with 3F12, whereas ⌬afkp80⫺ parasites showed little
reactivity (Fig. 4A). Importantly, 3F12 reactivity was restored
following introduction of AFKP80 expression in the ⌬afkp80⫺/
⫹AFKP80 “add-back” control (Fig. 4A).
These findings were supported by quantitative flow cytometry, again establishing similarly strong 3F12 reactivity in stationary phase WT, ⌬fkp40⫺, and ⌬afkp80⫺/⫹AFKP80 lines,
but with a significant decrease in 3F12 binding to ⌬afkp80⫺
(Fig. 4B). Importantly, these results are exactly those predicted
from the enzymatic assays. Although not evident by immunofluorescence, flow cytometry clearly showed a small increase in
3F12 staining (5– 6 FU versus 2 FU), in keeping with the residual
AKP activity in the ⌬afkp80⫺ mutant (⬃1%; Fig. 3). Thus, in
vivo AFKP80 is dominant, contributing the majority of total
cellular GDP-fucose and GDP-Arap synthetic activity.
LPG arabinosylation is greatly reduced in ⌬afkp80 but not in
⌬fkp40
LPG was purified, and the structure of the PG repeating units
was assessed by glyco-FACE (fluorophore-assisted carbohydrate electrophoresis). All lines showed similar patterns in
log phase, expressing primarily Gal- or Gal-Gal-modified PG
repeat units ([Gal-Man-P]⫺), as expected (Gal-Gal-Man-P or
Gal-Gal-Gal-Man-P; Fig. 4C, lanes labeled L). In stationary
phase, both WT and ⌬fkp40⫺ showed a decrease in the synthesis of the Gal-terminated PG repeats and the appearance of
Arap capped PG repeats (Arap-Gal-Gal-Man-P or Ara-GalGal-Gal-Man-P; Fig. 4C, lanes labeled with S). In contrast,
Arap-capped PG repeat units were barely detectable in stationary phase ⌬afkp80⫺ parasites (Fig. 4C). Western blot analysis of
log and stationary WT and ⌬afkp80⫺ parasites with monoclonal antibody WIC79.3, which preferentially detects the PG
repeat units with side chains terminating in Gal (36, 37),
showed that the sizes of the LPG were unaltered, with a slightly
larger size in stationary phase, consistent with the known
J. Biol. Chem. (2017) 292(25) 10696 –10708
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the three ORFs and their flanking regions were performed; for
both mutants, the PCR products of the proper size were
obtained (Fig. 2D, lanes labeled I, II, and III).
The ⌬afkp80⫺ and ⌬fkp40⫺ mutants showed no obvious
morphological change and grew at similar rates and to similar
stationary phase cell density as WT in the culture (⬃5 ⫻ 107
cells/ml; data not shown). To further control the nonspecific
effects arising from the disruption of FKP40 and AFKP80, we
restored the expression of FKP40 and AFKP80 in each mutant,
respectively. These complemented lines are referred to subsequently as ⌬afkp80⫺/⫹AFKP80 and ⌬fkp40⫺/⫹FKP40.

Surface arabinosylation is greatly reduced in ⌬afkp80ⴚ but
not in ⌬fkp40ⴚ single mutants

GDP-fucose is an essential metabolite for Leishmania

Plasmid segregation tests establish the essentiality of A/FKPs

Figure 4. Surface LPG arabinosylation is greatly reduced in ⌬afkp80ⴚ
but is unaffected in ⌬fkp40ⴚ. A, indirect immunofluorescence microscopy
of fixed promastigote in stationary phase with monoclonal antibody 3F12,
specific for D-arabinosylated PG repeating units. The complemented mutant
line ⌬afkp80⫺/⫹AFKP80 is also shown. B, flow cytometry of 3F12 binding
(shaded); controls omitting 3F12 antibody are shown (open). 10,000 cells were
counted for each cell line. AU, arbitrary fluorescent units. C, FACE analysis of
L. major LPG repeats in log phase (L) and stationary phase (S). A red star
denotes repeats containing D-Arap. LPG side chain structures corresponding
to each major band are noted on the right (Arap (A), Gal (G), and Man (M)). Lane
1, glucose oligomer standards (G2–G7).

increase in PG repeating units in this phase (supplemental Fig.
S2). These studies establish a dramatic loss of the Arap modification of LPG in the ⌬afkp80⫺ but not the ⌬fkp40⫺ mutant.
Failure to generate a ⌬fkp40ⴚ/⌬afkp80 double mutant by
“classic” sequential replacements
We reasoned that the properties of an A/FKP double mutant
could provide information about potential roles of the FKP
activities encoded by these genes. The ⌬afkp80⫺ mutant above
was the starting cell line to inactivate FKP40, using the
same constructs used successfully to create ⌬fkp40⫺. The
FKP40::BSD replacement fragment was first transfected into
⌬afkp80⫺, yielding clonal lines without difficulty that were
typed as ⌬afkp80⫺/⌬fkp40::BSD/FKP40, as expected. These
“3/4 A/FKP replacement” transfectants grew normally. One
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Recently, we introduced a plasmid segregational approach as
a more stringent, controlled test of gene essentiality (38). First,
we inserted AFKP80 into the pXNGPHLEO vector, which
expresses the GFP⫹ reporter gene, and transfected this into
the ⌬afkp80⫺ mutant (⌬afkp80⫺/pXNGPHLEO-AFKP80).
The genotype was confirmed by PCR tests, and these lines
showed normal arabinosylation, as expected (not shown). Then
we performed successive transfections with the FKP40::BSD
and FKP40::SAT replacement constructs used successfully to
inactivate FKP40 above (Fig. 5A). In contrast to the “classic”
four replacement attempts without ectopically expressed
AFKP80, each transfectant showed successful deletion of the
chromosomal copy of FKP40 and AFKP80 (Fig. 5B). PCR tests
confirmed that the marker replacements occurred as planned
and that the lines maintained the three intervening genes (as
described in Fig. 2A and supplemental Fig. S1; data not shown).
Thus, in the presence of ectopically expressed AFKP80, all
chromosomal A/FKP genes could be successfully eliminated,
generating ⌬afkp80⫺/⌬fkp40⫺/⫹pXNGPHLEO-AFKP80.
To perform plasmid segregation tests, parasites were grown
briefly (24 h) in the absence of phleomycin (selective for the
PHLEO marker of pXNG) (38). The parasites were then analyzed for GFP expression by flow cytometry, as a measure of
pXNG copy number. Two populations were revealed: a large
population of “bright” cells showing strong fluorescence bearing high copy numbers of pXNG-AFKP80 (⬎200 FU; Fig. 5C)
and a smaller population of “dim” cells, exhibiting control/
background fluorescence levels (2–20 FU; Fig. 5C), presumably
lacking pXNG-AFKP80 completely or bearing only a few
copies.
Fluorescence-activated cell sorting was then used to recover
single cells into individual wells of a 96-well microtiter plate,
containing M199 medium without phleomycin. For the bright
cell population, 264 of 480 cells inoculated with single bright
parasites grew out (55%), representing the “cloning/plating”
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line was then transfected with the targeting fragment
FKP40::SAT and plated on semisolid medium containing all
four marker-selective drugs. Whereas transfectants were
obtained without difficulty, PCR tests of over 50 transfectants
from three independent experiments showed that all contained
successful FKP40 replacements with the BSD- and SAT-selectable markers as well as retaining a copy of FKP40 (supplemental
Fig. S3). A similar strategy attempting to inactivate AFKP80 in
the ⌬fkp40⫺ mutant yielded similar results (data not shown).
The finding of seemingly successful “double replacements”
accompanied by retention of the WT gene has been reported
previously in attempts to target other essential genes in Leishmania and shown to arise from generation of aneuploid or
tetraploid parasites (31, 38), although the strength of this
conclusion has been mitigated by the appreciation of widespread aneuploidy within most laboratory strains of Leishmania (33). Measurements of DNA content by flow cytometry after propidium iodide staining of the quadruply
drug-resistant “double transfectants” showed a pattern similar
to that of WT (data not shown), suggesting that these lines were
likely to be aneuploid.

GDP-fucose is an essential metabolite for Leishmania

efficiency of cells subjected to this protocol. In contrast, growth
was seen in only 2 of 1920 of the dim parasites tested similarly
(0.1%; Fig. 5D). The two survivors still retained pXNG-AFKP80,
as judged by their ability to grow out in the presence of phleomycin and expression of GFP (data not shown), and were thus
likely to arise by imperfect sorting or other technical factors, as
seen previously (38). After correction for the plating/cloning
efficiency, we estimated that parasites lacking both A/FKP
genes were not obtained from ⬃1056 cells tested, thereby
extending the stringency of this conclusion beyond that possible by the classic approach (⬃50 cells tested).
Rescue of a ⌬afkp80ⴚ/⌬fkp40ⴚ double mutant by
introduction of a de novo GDP- fucose pathway
We hypothesized that inviability of the ⌬afkp80⫺/⌬fkp40⫺
mutant could arise if GDP-fucose was unexpectedly essential in
Leishmania. One way to test this was by “genetic metabolic
complementation” (38), through introduction of an alternative
source of GDP-fucose. Because Leishmania normally lack the
de novo pathway (Fig. 1A), we chose to introduce that from
T. brucei, comprising three enzymatic activities encoded by two
proteins (GMD and GMER) that have proven amenable to
genetic manipulation (29).
First, we inserted the two genes required (TbGMD and TbGMER) (29) into the bicistronic expression vector pIR1PHLEO,
yielding pIR1PHLEO-TbGMD-GMER (see “Experimental
procedures”). This construct was introduced into the penultimate “3/4” replacement line described earlier, yielding

⌬afkp80⫺/⌬fkp40::BSD/FKP40/⫹TbGMD-TbGMER. In this
experiment, the pIR vectors were transfected without linearization, which yields circular episomal transfectants; these overexpress passenger molecules, but not to the same extent as when
inserted into the rRNA locus (39).
Finally, the remaining FKP40 allele was removed by transfection with the FKP::SAT targeting fragment (Fig. 6). In contrast
to the studies above with WT lines lacking a functional de novo
GDP-fucose pathway, now all transfectants (⌬afkp80⫺/
⌬afkp40⫺/⫹TbGMD-TbGMER) showed loss of all A/FKP
alleles (Fig. 6). PCR tests showed that these lines retained all
chromosomal markers as planned, as well as the three intervening ORFs (similar to those shown in Fig. 2A, supplemental Fig.
S1, or Fig. 6C, or data not shown). Thus, expression of a functional de novo GDP-fucose synthetic pathway is able to bypass
the absence of all A/FKP genes.
⌬afkp80ⴚ/⌬fkp40ⴚ/ⴙTbGMD-TbGMER lacks GDP-Arap while
synthesizing abundant GDP-fucose
Sugar nucleotides were analyzed in WT and ⌬afkp80⫺/
⌬fkp40⫺/⫹TbGMD-TbGMER double mutants grown in logarithmic and stationary phase cells, as described previously
(27). As expected, no GDP-Arap was detectable in the
A/FKP-null mutant, whereas WT levels were similar to those
reported previously (Table 1) (27). Second, GDP-fucose
expression rose tremendously in the episomal TbGMD/
GMER transfectant A/FKP null mutant, increasing 129- or
J. Biol. Chem. (2017) 292(25) 10696 –10708
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Figure 5. Plasmid segregational test of A/FKP essentiality. A, workflow for deletion of A/FKP genes in the presence of ectopic AFKP80. First, a
pXNG-AFKP80 episomal expression construct was transfected into the ⌬afkp80⫺ mutant, yielding ⌬afkp80⫺/⫹pXNG-AFKP80. Following confirmatory
PCR tests, one clonal line was sequentially transfected with FKP40::BSD and FKP40::SAT targeting fragments, resulting in loss of FKP40. B, PCR confirmation of loss of chromosomal FKP40 and AFKP80 using primers as described in Fig. 2 and the presence of episomal AFKP80 confirmed by PCR using primer
f (specific in pXNG vector; SMB 3176) paired with the AFKP80 primer e (SMB2453). C, plasmid segregational tests of A/FKP essentiality. ⌬afkp80⫺/
⌬fkp40⫺/⫹pXNG-AFKP80 was grown for 24 h in the absence of phleomycin and analyzed by GFP flow cytometry. For subsequent quantitation and/or
sorting, weakly fluorescent (dim) and fluorescent (bright) parasites were defined as shown in the figure. D, single cells from both GFP dim and bright
populations gated (Fig. 5C) were sorted into 96-well plates containing M199 medium; the numbers sorted and their growth and properties are shown.
The two survivors from the “dim” and 12 of the 12 from the “bright” population sort were tested for retention of pXNGPHLE-AFKP80 by growth in
medium containing phleomycin.

GDP-fucose is an essential metabolite for Leishmania
phase; Table 1). This suggests that the parasites were able to autoregulate and compensate for the increased flux through the GDPmannose synthetic pathway toward GDP-fucose.
Little change was seen in the UDP-GlcNAc or UDP-hexose
levels in log phase, although a modest drop to 16 and 22% of WT
levels, respectively, was seen in stationary phase (Table 1). Neither change reached statistical significance (p ⬍ 0.05) in the
studies performed. Curiously, perturbations of UDP-glucose
and/or galactose synthesis following genetic perturbations of
UDP-sugar pyrophosphorylase (USP) or UDP-Glc pyrophosphorylase (UGP) also led to changes in GDP-fucose levels (40).
This suggests the possibility that GDP-fucose and UDP-Gal
synthesis may be co-regulated for some reason, perhaps related
to the structure of hypothetical fucoconjugates, although this
has not been studied further.
Preliminary evidence for fucoconjugates in L. major

95-fold in logarithmic or stationary phase cells, respectively
(Table 1).
These data established that the de novo pathway had been successfully transplanted into L. major. Importantly, the great
increase in GDP-fucose over that seen in WT was not accompanied by a significant drop in the vital GDP-mannose precursor in
either growth phase (which, in fact, rose somewhat in stationary
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Figure 6. Genetic metabolite complementation permits the recovery of
⌬afkp80ⴚ/⌬fkp40ⴚ double null mutants. A, workflow for the deletion of
chromosomal FKP40 in the ⌬afkp80⫺ mutant, in the presence of the de novo
GDP-fucose pathway encoded by TbGMD and TbGMER. First, pIR1PHLEOTbGMD-GMER was transfected into the intermediate line ⌬afkp80⫺/
⌬fkp40::BSD/FKP40 depicted in Fig. 6A (this line can be considered a “3/4”
A/FKP replacement). After confirmatory PCR tests, this line was then transfected with the FKP40::SAT targeting fragment to replace the last copy of
FKP40, yielding the line termed ⌬afkp80⫺/⌬fkp40⫺/⫹TbGMD-TbGMER. B,
scheme of primers used to confirm loss of all A/FKP alleles. Primer 1,
SMB2828; primer 2, SMB3544; primer 3, SMB2446; primer 4, SMB3752;
primer 5, SMB 2450; primer 6, SMB2829. C, PCR tests showing loss of all
four A/FKP alleles in ⌬afkp80⫺/⌬fkp40⫺/⫹TbGMD-TbGMER and the presence of all four selective markers. Lines 1–5 represent five independent
lines with four replacements removing all A/FKP genes. Not shown are PCR
tests confirming the presence of the pIR1PHLEO-TbGMD-TbGMER, whose
presence is confirmed by GDP-fucose synthesis (Table 1).

As yet no evidence of fucosylated molecules occurring naturally in L. major has been presented, although when provided
with high levels in the medium, fucose can be substituted for
D-Arap on LPG (41). For preliminary evidence of fucoconjugates, we used cryo-electron microscopy and binding to biotinylated Ulex europaeus agglutinin I (UEA-I) lectin, which recognizes terminal ␣1,2-fucosyl linkages (42) in WT and the
⌬afkp80⫺/⌬fkp40⫺/⫹TbGMD-TbGMER mutant synthesizing
elevated GDP-fucose. UEA-I-conjugated gold particles were
counted across several cellular compartments in both the
mutant and WT parasites (Fig. 7A,). Increased numbers of particles were seen only in the flagellar pocket and on the parasite
surface in the GDP-fucose-overexpressing TbGMD/GMER
transfectant (3– 6-fold; Fig. 7B). Comparable levels were
seen in the cytosol and other compartments, including the
mitochondrion, endoplasmic reticulum, and Golgi apparatus (Fig. 7B).
The cryo-EM data were confirmed by flow cytometry of nonpermeabilized cells allowed to bind the fucose-specific fluoresceinated UEA-I. WT Leishmania showed little reactivity
(Fig. 7C), whereas ⌬afkp80⫺/⌬fkp40⫺/⫹TbGMD-TbGMER
showed a significant increase in fluoresceinated UEA-I fucose
lectin binding (⬃10-fold; Fig. 7C, gray shading). Importantly,
the addition of fucose totally inhibited the reactivity (Fig. 7C,
dotted line).
The Leishmania genome predicts at least five candidate arabinosyl/fucosyl transferases, including the two encoded by
SCA1/2 that reside within the secretory pathway, where they
normally mediate LPG arabinosylation or fucosylation if cells
are provided with high levels of fucose (19, 41). LPG was isolated from WT and ⌬afkp80⫺/⌬fkp40⫺/⫹TbGMD-TbGMER,
hydrolyzed, and analyzed by glyco-FACE (see “Experimental
procedures”). In these analyses, fucose was undetectable in WT
LPG, whereas it was present at about 5– 8% the level of mannose in the GDP-fucose overexpresser (which occurs mostly as
a single residue within the LPG phosphoglycan repeats) (Fig.
7D). This is consistent with the hypothesis that the elevated
UEA-I reactivity in the TbGMD/GMER expresser mainly arises
from fucosylated LPG. Regardless, our data establish that the
high levels of GDP-fucose in the TbGMD/GMER expressers
are accessible within the secretory pathway.

GDP-fucose is an essential metabolite for Leishmania
Table 1
Nucleotide-sugar levels in WT and the ⌬afkp80ⴚ/⌬fkp40ⴚ/ⴙTbGMD-TbGMER mutant L. major

The averages ⫾ S.D. from 2–3 experiments with 2–3 replicas each are shown. Asterisks mark results where the mutant significantly differs from WT; *, p ⬍ 0.05; **, p ⬍ 0.005
(two-sided t test with unequal variance). S.D. and statistical tests were calculated using Microsoft Excel 2010. ND, not detectable.
Log phase
Nucleotide sugar
UDP-hexose
UDP-GlcNAc
GDP-Man
GDP-Arap
GDP-Fuc

WT
12.9 ⫾ 8
23.8 ⫾ 9.2
1.07 ⫾ 0.49
0.17 ⫾ 0.11
0.06 ⫾ 0.11

Stationary phase

⌬afkp80ⴚ/ ⌬fkp40ⴚ/
ⴙTbGMD-TbGMER
pmol/107 cells

12.6 ⫾ 8.6
17.5 ⫾ 13.9
0.57 ⫾ 0.72
ND
6.7 ⫾ 5.3*

WT
1.05 ⫾ 0.42
1.94 ⫾ 1.30
0.20 ⫾ 0.05
0.21 ⫾ 0.14
0.35 ⫾ 0.14

⌬afkp80ⴚ/ ⌬fkp40ⴚ/
ⴙTbGMD-TbGMER
pmol/107 cells

0.26 ⫾ 0.16**
0.31 ⫾ 0.24**
0.20 ⫾ 0.21
ND
11.4 ⫾ 5.5**
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Figure 7. Evidence for fucosylation in WT and ⌬fkp40ⴚ/⌬afkp80ⴚ/ⴙTbGMD-GMER L. major. A, binding of biotinylated UEA-I lectin/streptavidin gold
particles detected by cryo-EM (see “Experimental procedures”). FP, flagellar pocket; k, kinetoplast; N, nucleus. B, quantitation of cellular location of UEA-I-bound
gold particles in WT and mutants. Three experiments were performed, counting 10 cells from each line; the averages and S.D. values are shown, calculated
using Microsoft Excel 2010. “Other” locations include the mitochondrion, Golgi apparatus, and endoplasmic reticulum. C, WT or ⌬afkp80⫺/⌬fkp40⫺/⫹TbGMDTbGMER parasites were washed with PBS, incubated with fluoresceinated UEA-I lectin (UEAI; shaded) or PBS (open), or fluoresceinated UEA-I lectin plus 25 mM
fucose (dotted), and then subjected to flow cytometry. Representative experiments from three independent replicas for each line are shown. D, glyco-FACE
analysis. Lane 1, Man ⫹ Gal standard; lane 2, fucose standard; lane 3, WT; lane 4, ⌬fkp40⫺/⌬afkp80⫺/⫹TbGMD-GMER. A representative experiment from three
independent replicas is shown.

The AFKP80 and FKP40 proteins are located in the cytoplasm
In trypanosomatids, nucleotide sugars are synthesized in the
cytosol or glycosome (27, 43) and enter the secretory pathway
through the action of nucleotide-sugar transporters (44). GDPmannose, GDP-fucose, and GDP-Arap have been shown previously to be substrates for the nucleotide-sugar transporter
encoded by LPG2 (Fig. 1A) (17, 45, 46). We constructed N-terminal GFP-tagged versions of both FKP40 and AFKP80 and

introduced them separately into WT parasites. Fluorescence
microscopy showed that the GFP-tagged FKP40 and AFKP80
were both distributed throughout the whole-cell WT (Fig. 8),
consistent with an absence of predicted cellular targeting signals within these two polypeptides. ⌬afkp80⫺/⫹GFP-AFKP80
transfectants showed full 3F12 (Arap-LPG) reactivity, confirming that the GFP tag did not compromise enzymatic activity
(data not shown).
J. Biol. Chem. (2017) 292(25) 10696 –10708
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Figure 8. GFP-tagged L. major FKP40 and AFKP80 are localized in the
cytoplasm. Wild-type L. major expressing FKP40 or AFKP80 bearing an Nterminal GFP⫹ tag (WT/⫹pXG-GFP-FKP40 or WT/⫹pXG-GFP-AFKP80) were
stained with Hoechst 33342 dye and visualized by fluorescence microscopy.
Left panels, GFP fluorescence; center panels, Hoechst fluorescence; right panels, merged.
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Discussion
In this work, we used single and double gene knockouts as
well as “genetic metabolic complementation” to probe the contributions of the two closely related A/FKP genes to L. major
metabolism. Previous studies of recombinant enzymes had
shown that only AFKP80 could mediate synthesis of GDP-DArap, whereas both AFKP80 and FKP40 could mediate synthesis of GDP-fucose (22, 23).4 Consistent with these data, ablation
of AFKP80 resulted in reduction of AKP activity to trace levels
as well as an 85% decrease in FKP activity (Fig. 3). Correspondingly, LPG arabinosylation was entirely eliminated, suggesting
that this is the sole route of GDP-Arap synthesis in the parasite
(Fig. 4). Because LPG itself is not essential in vitro (47), it was
unsurprising that lack of LPG arabinosylation had no effect on
cell viability or growth.
In contrast, for FKP40, which is able only to mediate the
synthesis of GDP-L-fucose, genetic ablation yielded no detectable phenotype. Cells grew normally, with WT morphology,
and maintained LPG side chain arabinosylation (Fig. 4). This
could not be attributed to a lack of FKP40 expression or activity,
because the ⌬afkp80⫺ mutant, which retains only FKP40,
showed about 15% of WT levels of GDP-fucose synthesis (Fig.
3), consistent with studies of recombinant enzymes in vitro.4
Given the paucity of evidence for an important role for L-fucose in Leishmania and the nonessential role for D-Arap, we
attempted to generate a double A/FKP mutant, expecting that
this would confirm the lack of a requirement for GDP-fucose or
fucosylation. However, we were unable to create the double
mutant. Various controls ruled out technical issues, and the
double mutant could be obtained in the presence of ectopic
AFKP80 expression (Fig. 5). Importantly, plasmid segregation
tests of ⬎ 1000 cells expressing ectopic AFKP80 in a double
chromosomal null background showed that it was impossible
to generate cells lacking both of the A/FKP genes (Fig. 5).
These data raised the possibility that unlike GDP-Arap,
GDP-fucose was an essential metabolite in L. major. To confirm this hypothesis, we employed the approach of “genetic
metabolic complementation” (38), introducing an alternate,
“bypass” route of metabolite synthesis to confirm the role of the

primary target (provision of GDP-fucose). This was accomplished by introduction of the well-characterized de novo GDPfucose pathway from the closely related protozoan T. brucei,
which, inverse from Leishmania, lacks a salvage pathway (29).
Successful expression was shown by the synthesis of high levels
of GDP-fucose (Table 1). In the presence of an active de novo
GDP-fucose pathway, we were readily able to generate chromosomal null mutants lacking any A/FKP genes whatsoever (Fig.
6). These data argue strongly that GDP-fucose is an essential
metabolite in Leishmania.
We exploited the greatly elevated levels of GDP-fucose in
transfectants expressing TbGMD/GMER to facilitate visualization of fucoconjugates normally present at undetectably low
levels. Increased UEA-I lectin binding signal was seen over the
flagellar pocket and cell surface (Fig. 7, B and C), potentially
arising from any or all of the candidate fucosyltransferases, targeted to the secretory pathway. Some evidence of cytoplasmic
fucoconjugates also emerged, (Fig. 7, A–C). The Leishmania
genome encodes a candidate homolog of SKP1 (LmjF.11.1210),
a cytosolic protein identified first in Dictyostelium and known
to bear essential fucosyl modifications in other unicellular
microbes (48, 49). We did not see prominent staining of nuclear
structures, in contrast to Toxoplasma gondii, where fucosylation of nuclear pore complexes may occur (50).
Collectively, our data suggest that L. major may synthesize a
variety of fucoconjugates, at least one of which must be essential. Whereas LPG can be fucosylated in the presence of high
levels of fucose (exogenous or endogenous; Fig. 7D) (41), the
essential glycoconjugate(s) is unlikely to be LPG, because LPGnull mutants are viable in vitro (47). Because Leishmania lack
the de novo fucose pathway and rely entirely on salvage, we
speculate that in our studies in vitro and probably in vivo, the
fucose requirement may be satisfied through ingestion and
catabolism of fucosylated proteins.
The de novo GDP-fucose pathway is also essential in T. brucei, where the essential fucoconjugate similarly remains
unknown (29). In contrast, the T. cruzi genome predicts the
presence of both the de novo and salvage pathways. T. cruzi
synthesizes a complex fucose-containing surface glycan
attached to gp72 (51–53), ablation of which results in flagellar
detachment (54). Although the T. brucei gp72 ortholog is not
known to be fucosylated, its ablation leads to death preceded by
flagellar detachment and blockage of cell division (55, 56).
The Leishmania genome predicts at least one gp72 ortholog
(LmjF10.0630), whose role(s) and/or modifications have not
been studied. GDP-fucose synthesis and fucoconjugates have
also been described in apicomplexan parasites. In T. gondii, the
de novo GDP-fucose pathway appears to be essential, possibly
due to a role in nuclear pore complex modification (50). Protein
O-fucosylation of the surface CSP and TRAP sporozoite proteins of the malaria parasite Plasmodium falciparum has been
described (57), although the de novo pathway for GDP-fucose
synthesis does not appear to be essential (58, 59).
Formally, the ability of the GDP-fucose de novo pathway to
rescue pan-A/FKP mutants might not imply that GDP-fucose
itself is essential. Potentially, an unknown downstream metabolite could be responsible, or perhaps GDP-Arap itself is essential, and GDP-fucose rescues simply by mimicry. We think

GDP-fucose is an essential metabolite for Leishmania
these scenarios are unlikely to rule out a role for GDP-fucose for
the following reasons: 1) GDP-fucose is typically a terminal
metabolite, not undergoing further modification; 2) WT
L. major synthesize GDP-fucose (27); and 3) candidate fucoconjugates have been reported in closely related species (24 –
26, 60).
Instead, it seems more likely that there remain new, unidentified fucoconjugates to be found. In all probability, these will differ
significantly from known parasite glycoconjugates, probably
occurring at low levels, yet playing vital role(s) in parasite biology.
Our studies now elevate the priority of studies seeking to characterize the fucoconjugate repertoire of Leishmania, at least one of
which is predicted to play a vital role(s) in parasite biology.

Flow cytometry and immunofluorescence microscopy
Parasites were washed in PBS and fixed with 4% paraformaldehyde for 10 min at room temperature. For immunofluorescence labeling, cells were immobilized on poly(L-lysine)-coated
glass coverslips and blocked with 5% normal goat serum. Fixed
parasites were then sequentially incubated for 1 h at room temperature with primary and secondary antibodies diluted in 5% normal
goat serum (63). Flow cytometry was performed with a BD Biosciences FACSCalibur system. Monoclonal antibody 3F12 was used
at 1:100 dilutions, Fluor 488 goat anti-mouse IgG was used at
1:1000, and fluoresceinated UEA-I was used at 10 g/ml.
Targeted gene replacement of L. major FKP40 and AFKP80
Fusion PCR was used to generate replacement constructs.
Briefly, the flanking regions and drug resistance cassettes were
amplified separately by PCR using primers that produce overlapping ends. An 870-nt 5⬘ region and a 930-nt 3⬘ region of
FKP40 were amplified using primer pairs SMB 2664/2665 and
SMB 2666/2667 (primer sequences are listed in supplemental
Table S1). The ORFs of blasticidin (BSD) and nourseothricin
(SAT) were amplified from pXGBSD (strain B4098) and pXGSAT (strain B2352), respectively, using primers with added
linker sequence. A linear DNA BSD or SAT between 5⬘- and
3⬘-flanking regions of FKP40 was synthesized in a second round
of PCR by mixing the purified PCR products of the flanking
regions and a drug-resistance cassette as templates using prim-

Subcellular localization of L. major FKP40 and AFKP80
The ORFs of FKP40 and AFKP80 were excised from pGEMFKP40 (B5988) and pGEM-AFKP80 (B5989) by digestion with
NotI and inserted in the sense orientation of the NotI site of
pXG-GFP⫹2 (B2952), yielding pXG-GFP-FKP40 (B6250) and
pXG-GFP-AFKP80 (B6251). Both constructs were transfected
J. Biol. Chem. (2017) 292(25) 10696 –10708
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Experimental procedures
Leishmania culture and transfection
L. major strain Friedlin V1 (MHOM/IL/80/Friedlin) was
grown at 26 °C in M199 medium (U.S. Biologicals) containing
10% heat-inactivated fetal bovine serum and other supplements
as described (61). Leishmania cells were transfected by electroporation using a high-voltage protocol (62). Following transfection, cells were allowed to grow for 16 –24 h in M199 medium
and then plated on semisolid media containing 1% Nobel agar
(Fisher) and appropriate selective drugs (50 g/ml hygromycin
B, 30 g/ml puromycin, 10 g/ml blasticidin, 100 g/ml
nourseothricin, 10 g/ml phleomycin, and/or 10 g/ml G418).
Individual colonies were picked and grown in liquid medium in
same drug concentration as used in plates. Clones were maintained in selective medium and then removed from selection
for one passage before experiments.

ers SMB 2664/2667 and then inserted into pGEM-T (Promega)
to make pGEM-FKP40-BSD (strain B5925) and pGEM-FKP40SAT (B5926), respectively. The targeted linear fragments were
liberated from pGEM-FKP40-BSD and pGEM-FKP40-SAT by
digestion with BsmI and DraIII, respectively; treated with calf
intestinal phosphatase; purified after agarose gel electrophoresis; and transfected into LmFV1. The heterozygous mutant
⌬fkp40::BSD/FKP40 was obtained by transfecting 5 g of
FKP40::BSD fragment into WT LmFV1 promastigotes as
described previously (62). A second targeting round with
FKP40::SAT resulted in ⌬fkp40::BSD/⌬fkp40::SAT, referred to
as the ⌬fkp40⫺ mutant. Before study, all lines were passed
through mice once by injecting hind footpads of BALB/c mice
(Charles River Laboratories, Wilmington, MA) with a large
inoculum (1–5 ⫻ 107) of stationary-phase parasites and recovering parasites by needle aspiration of footpad regardless of
pathogen 4 weeks afterward.
A similar strategy was used to create the ⌬afkp80⫺ mutant.
AFKP80 allelic replacement constructs were made by inserting
ORFs encoding hygromycin B (HYG) or puromycin (PAC) resistance between 930-nt 5⬘ and 980-nt 3⬘ AFKP80 flanking
regions, making pGEM-AFKP80-HYG (strain B5950) and
pGEM-AFKP80-PAC (strain B5961). Targeting fragment was
liberated from pGEM-AFKP80-HYG by NspI and StuI, purified
before transfection into LmFV1. The second round replacement was performed by electroporation of AFKP80::PAC fragment excised from pGEM-AFKP80-PAC (strain B5961) by
NdeI and KpnI, resulting in ⌬afkp80::HYG/⌬afkp80::PAC,
hereafter referred to as the ⌬afkp80⫺ mutant. Using the same
constructs and similar methods, we attempted unsuccessfully
to make a ⌬fkp40⫺/⌬afkp80⫺ double mutant by inactivating
FKP40 in the afkp80⫺ mutant or AFKP80 in the fkp40⫺ mutant.
The ORFs of FKP40 and AFKP80 were PCR-amplified from
LmFV1 genomic DNA using primer pairs SMB 2828/2829 with
an XmaI site included. For expression, an optimal translation
sequence (CCACC) was added upstream of the ORF starting
codon in primer 2828. Because there is only a 3-base difference
in the middle of the ORFs between FKP40 and AFKP80, PCR
products were a mixture of FKP40 and AFKP80. PCR products
were then directly cloned into pGEM-T vector by TA cloning.
Some clones were sequenced, sorting out pGEM-FKP40
(B5988) and pGEM-AFKP80 (B5989). The ORFs were then liberated with XmaI and inserted in the sense direction of the
XmaI expression site of pXG (NEO-B1288), creating pXGFKP40 (B5990) and pXG-AFKP80 (B5992). To restore the
expression of FKP40 or AFKP80, fkp40⫺ and afkp80⫺ mutants
were transfected with 5 g of pXG-FKP40 and pXG-AFKP80,
respectively. For simplicity, in this work, the transfectants
⌬fkp40::BSD/⌬fkp40::SAT [pXG-FKP40] are designated ⌬fkp40⫺/⫹
FKP40; similarly, the transfectants ⌬afkp80::HYG/⌬afkp80::
PAC [pXG-AFKP80] are designated ⌬afkp80⫺/⫹AFKP80.
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into WT LmFV1, and clonal lines were obtained and verified.
As a control, pXG-GFP-AFKP80 was also transfected into
⌬afkp80⫺ mutant. WT/⫹GFP-FKP40 and WT/⫹GFP-AFKP80
promastigotes were fixed with 0.5% (w/v) paraformaldehyde in
PBS and immobilized on coverslips. Hoechst 33342 staining (5
g/ml in PBS) was performed to visualize nuclear and kinetoplast DNAs.
Cytosolic fractionation and enzymatic assay

Purification and analysis of LPG
LPG was extracted and purified by phenyl-Sepharose chromatography (65). Briefly, exponentially growing (1–2 ⫻ 106
cells/ml) or stationary phase (5 ⫻ 107 cells/ml) parasites were
extracted in solvent E (H2O/ethanol/diethyl ether/pyridine/
NH4OH; 15:15:5:1:0.017); dried under a stream of N2; resuspended in 0.1 N acetic acid, 0.1 M NaCl; and applied to a column
of phenyl-Sepharose (1 ml), equilibrated in the same buffer.
LPG was eluted with solvent E. The PG repeats of LPG were
generated by depolymerization under mild acid conditions
(0.02 N HCl, 15 min at 60 °C) and dephosphorylated with E. coli
alkaline phosphatase (5 units/ml, 16 h at 37 °C) (7, 65). Aliquots
of dephosphorylated PG repeats were fluorophore-labeled at
the reducing ends with 8-aminonaphthalene-1,3,6-trisulfate
and analyzed by FACE according to the manufacturer’s specifications (Glyko Inc., Novato, CA).
Purified LPG was resolved by 12% SDS-PAGE and electroblotted onto Hybond ECL nitrocellulose membranes (Amersham Biosciences). Mouse monoclonal antibody WIC79.3 was
used to detect LPG (1:1000 dilution) (66). An enhanced chemiluminescence detection system (Amersham Biosciences) was
used to detect signal.
Double knock-out A/FKPs in the presence of ectopically
expressed AFKP80
The ORF was released from pXG-AFKP80 (B5992) by digestion with SmaI and blunt-ligated into the BglII site of pXNG5Phleo (B6432), yielding pXNG5-Phleo-AFKP80 (B6481). The
construct was transfected into ⌬afkp80⫺ mutants, yielding
⌬afkp80⫺/⫹pXNG-AFKP80, whose activity was confirmed by
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Single-cell sorting
Before cell flow cytometry, ⌬fkp40⫺/⌬afkp80⫺/⫹pXNGAFKP80 cells were grown in M199 without any drug for 24 h,
washed with PBS, and filtered through CellTrics 50-m filters
(Partec). Single-cell sorting was then performed based upon
their GFP fluorescence using a Dako MoFlo high-speed cell
sorter, with single cells selected by stringent gating on forwardand side-scatter parameters. Single cells were placed into individual wells of 96-well plates, each containing 150 l of M199
medium. Plates were incubated at 26 °C for 2 weeks, and parasite growth was scored.
Cloning and overexpression of TbGMD and TbGMER in
L. major
GMD and GMER ORFs (GenBankTM accession numbers
AM746334 and AM746335) were amplified by PCR from
genomic DNA of T. brucei 427 using primer pairs with XmaI or
BglII restriction sites added (SMB 3448/3449 for GMD, SMB
3450/3451 for GMER). PCR products were digested with XmaI
(GMD) and BglII (GMER), ligated into the XmaI and BglII sites
of pIR1Phleo (B6175), respectively, producing pIR1Phleo-TbGMD-GMER (B6339). The construct was electroporated into
the third targeting round (“3/4”) afkp80⫺/⌬fkp40::BSD/FKP40,
resulting in afkp80⫺/⌬fkp40::BSD/FKP40/⫹TbGMD-GMER.
The resulting cell was then submitted to the fourth-round
replacement with FKP40::SAT to replace the last copy of
FKP40, yielding fkp40⫺/afkp80⫺/⫹TbGMD-GMER.
Nucleotide-sugar analysis
Sugar nucleotide extraction and analysis were performed as
described (27). Briefly, cells were pelleted by centrifugation,
washed in ice-cold PBS, and lysed in 70% ethanol in the presence of 20 pmol of the GDP-glucose as an internal standard
(Sigma). The lysate was centrifuged to remove insoluble material, and the supernatant was extracted with butan-1-ol to
remove lipids. Sugar nucleotides were extracted from the
resulting aqueous phase using EnviCarb graphitized carbon
columns (Supelco) as described previously (67). The eluted
sugar nucleotides were analyzed by multiple-reaction monitoring LC-MS/MS (27).
Electron microscopy
Parasites were fixed in 4% paraformaldehyde, 0.05% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM PIPES,
0.5 mM MgCl2, pH 7.2, for 1 h at 4 °C. Samples were then
embedded in 10% gelatin and infiltrated overnight with 2.3 M
sucrose, 20% polyvinylpyrrolidone in PIPES/MgCl2 at 4 °C.
Samples were trimmed, frozen in liquid nitrogen, and sectioned
with a Leica Ultracut UCT cryo-ultramicrotome (Leica Microsystems Inc., Bannockburn, IL). 50-nm sections were blocked
with 5% FBS, 5% normal goat serum and subsequently incubated with biotinylated UEA-I (1:20) (Vector Laboratories, Inc.,
Burlingame, CA) followed by streptavidin conjugated to 15-nm
colloidal gold (BB International, Cardiff, UK). Sections were
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Stationary phase parasites were suspended in 12 ml of lysis
buffer (100 mM HEPES, pH 7.4, 50 mM KCl, 10% glycerol, and
EDTA-free protease inhibitor mixture) and lysed by nitrogen
cavitation (1500 –2000 p.s.i., incubated on ice for 30 min). The
crude lysate was centrifuged at 100,000 ⫻ g for 1 h at 4 °C, and
the supernatant was used as a source of cytosolic enzymes. The
standard assay mix contained 100 l of the cytosolic fraction, 5
mM final concentration each of ATP, GTP, and MgSO4; 1 unit
of inorganic pyrophosphatase; and 0.15 Ci of D-[5-3H]arabinose (20 Ci/mmol) or L-[6-3H]fucose (60 Ci/mmol). Assay mixtures were incubated at 37 °C for 16 h and terminated by boiling
for 1 min. Nucleotide sugars were purified by anion-exchange
chromatography, as described earlier (64). Briefly, the reaction
mixtures were applied to a column (1.5 ⫻ 7.5 cm) of DE-52 cellulose and washed with 50 ml of water. The products of the reaction
were eluted with a 120-ml gradient (0–250 mM) of (NH4)HCO3.
GDP-Arap and GDP-fucose emerged with 120–150 mM
(NH4)HCO3 and were subjected to scintillation counting.

3F12 agglutination. The cell was further submitted to third- and
fourth-round replacements with FKP40::BSD and FKP40::SAT,
resulting in ⌬fkp40⫺/⌬afkp80⫺/⫹pXNG-AFKP80.
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washed in PIPES buffer, followed by a water rinse, and stained
with 0.3% uranyl acetate, 2% methyl cellulose. Samples were
viewed with a JEOL 1200EX transmission electron microscope
(JEOL USA Inc., Peabody, MA). Parallel controls omitting the
biotinylated UEA-I were consistently negative at the concentrations of streptavidin used.
Author contributions—H. G., M. A. J. F., S. J. T., and S. M. B. designed
the study; H. G., N. M. N., and G. B. performed the experiments; all
authors were involved in data analysis; and H. G. and S. M. B. wrote
the paper.
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SUPPLEMENTAL FIGURES
Figure S1. PCR confirmation drug marker replacements within A/FKP80 single gene
knockouts. Panel A shows the map of the planned AFKP80::HYG and AFKP80::PAC
replacements, and Panel C shows the map of the planned FKP40::BSD and FKP40::SAT
replacements. The large grey boxes depict the HYG, PAC, BSD and SAT ORFs, the narrow
flanking grey and white bars depict regions conserved between A/FKPs on the 5’ and 3’ sides
respectively, and the narrow black bar depicts the extent of the targeting fragments. The analysis
of the A/FKP coding regions is shown in Figs. 2B, C. Panel B. PCR confirmation of planned
integration of drug resistant markers in a representative Δafkp80- mutant. Primers outside the 5’and 3’-flanking regions used for gene replacement and primers inside drug marker ORFs were
used for PCR to confirm the integration of the drug marker ORFs into the chromosome. Primers
a/e and d/f establish the left (5’) and right side (3’) of PAC replacement (ℓ PAC/r PAC), and
primers a/b and d/c establish the left (5’) and right side (3’) of HYG replacement (ℓ HYG/r HYG).
Primer a, SMB2796; e, SMB 2889; f, SMB2888; b, SMB2566; c, SMB2565; d, SMB2793.
Panel D. PCR confirmation of planned integration of drug resistant markers in a representative
∆fkp40- mutant. Primers g/l and k/j establish the left (5’) and right side (3’) of SAT replacement
(ℓ SAT/r SAT), and primers g/h and i/j establish the left (5’) and right side (3’) of BSD
replacement (ℓ BSD/r BSD). Primer g, SMB2783; l, SMB 2768; k, SMB2769; h, SMB2555; i,
SMB2556; j, SMB2784.

Figure S2. The size of LPG in logarithmic and stationary phase is unchanged in the
arabinose-deficient Δafkp80- mutant. A western blot with antibody WIC79.3 of LPG purified
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from logarithmic or stationary growth phases from both WT and Δafkp80- is shown. WIC79.3
recognizes Gal-modified LPG (66).
Figure S3. Attempts to generate A/FKPs double mutants by successive rounds of
replacement yielded 4 successful replacements but retention of FKP40. Panel A. Planned
disruption of FKP40 by homologous gene replacement by methods depicted in Fig. 2, S1. In a
third round of gene replacement, the ∆afkp80- mutant was transfected with FKP40::BSD. PCR
tests (not shown) confirmed this was successful, yielding a line lacking 3 of the 4 A/FKP alleles
(∆afkp80-/FKP40::BSD/FKP40). In a fourth round, this line was transfected with the
FKP40::SAT targeting fragment, with the expectation of yielding homozygous A/FKP double
mutants. Panel B. PCR tests established that this line lacked AFKP80 (lanes labeled r AFKP),
but retained FKP40 (r FKP lanes) despite the presence of the planned FKP40::BSD and
FKP40::SAT replacements (lanes labeled ℓ BSD, r BSD, ℓ SAT and r SAT). See Fig. S1 for
location of primers used in PCR tests and not shown are data for the AFKP80 replacements
(Figs. 2, S1).
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Supplemental Table.
Table S1. Oligonucleotides used in this work.
Primer
SMB2446
SMB2450
SMB2451
SMB2453
SMB2555
SMB2556
SMB2557
SMB2558
SMB2561
SMB2562
SMB2565
SMB2566
SMB2630
SMB2631
SMB2664
SMB2665
SMB2666
SMB2667
SMB2668
SMB2669
SMB2670
SMB2671
SMB2768
SMB2769
SMB2783
SMB2784
SMB2793
SMB2796
SMB2828
SMB2829
SMB2830
SMB2889
SMB2890
SMB3176
SMB3448
SMB3449
SMB3450
SMB3451

Sequence
AGCTGCGCGACGCTGAGTTCCTGCACTA
GATTGAGCAGATGCTGACTGCTGGT
TACATGTACATGTGCGCGAAGGACGAG
GACAGGAACGACCTCTTC
GGTAACGGTGCGGGCTGACGCCACCATGGGCCAAGCCTTTGTCTCA
CGAGATCCCACGTAAGGTGCTTAGCCCTCCCACACATAACCAGAG
GGTAACGGTGCGGGCTGACGCCACCATGACCGAGTACAAGCCC
CGAGATCCCACGTAAGGTGCTCAGGCACCGGGCTTGCG
GGTAACGGTGCGGGCTGACGCCACCATGAAAAGCCTGAACTC
CGAGATCCCACGTAAGGTGCCTATTCCTTTGCCCTCG
AATACGAGGTCGCCAACATC
GAAAGCACGAGATTCTTCGC
GGTAACGGTGCGGGCTGACGCCACCATGAAGATTTCGGTGATCC
CGAGATCCCACGTAAGGTGCTTAGGCGTCATCCTGTGCTCC
CATGCCATGGGGCGAAACAGCGACCACA
CGTCAGCCCGCACCGTTACCCGTGGCACACGGCTCTGTG
GCACCTTACGTGGGATCTCGAGAGGCGTGCGGCGGTGTG
GGGAATTCCATATGCGCCTCAAGCTCTACCCACC
CATGCCATGGCATCCCTGCCGAACGCCGAACC
CGTCAGCCCGCACCGTTACCGGTTGCAGGGGAGGCTGAAGA
GCACCTTACGTGGGATCTCGTCTTAGAGGCGTGCGGCGGT
GGGAATTCCATATGGAGGTGCGATGCGGTGTTCGGGGTT
CTTGGTCGGATAGGTGCAC
AGCGATGTACTGGTACTGG
CATAGCAGCTGAGCAGCAG
TGGTGCGACGCAGCCGTAG
AGATGAGGAACCTAGAGAG
CCCGTATTCCTTGTCCTTTCATGGTACC
TCCCCCCGGGCCACCATGAACGTGAGCTTTCTCTTCAGCC
TCCCCCCGGGCTAAGACCGGCTGATCTGGAGGCCGGACG
GGAGCTGATGCGATGCTCTCC
ACCGTGGGCTTGTACTCGG
ATTGTTCAGGCTTCAAGCGACC
CAGCAGCCCTCTATATACCCGC
TCCCCCCGGGCCACCATGGAACAAAAACTCATCTCAGAAGAGGATCT
GTCAGCACGTCGACTGGC
TCCCCCCGGGTATTGCCCCGCTGCTCAACAC
GGAAGATCTCCACCATGTACCCATACGATGTTCCAGATTACGCTTTAG
GGTCCCTACCGAGT
GGAAGATCTTCACTTCCGTGCGACATCGTAGTT

4

SMB3522
SMB3523
SMB3524
SMB3525
SMB3526
SMB3527
SMB3752

CCAAGAGGTGTCTAATCGCTGC
GACTGGACAGTCAACGATCCGC
GCGGATCGTTGACTGTCCAGTC
GAAGAAGCAGCTCATCAAGTGG
CCACTTGATGAGCTGCTTCTTC
ACGCACCCTCTCTAGGTTCC
AACTGCTGCTGCAGCAGCGCAACC

Restriction sites are underlined and linker sequences are in bold.
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